Clinical Trial Update: IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing intravenous iron isomaltoside 1000 (Monofer) with iron sucrose in iron deficiency anemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Iron sucrose (iron sucrose)
• Monofer (Ferric derisomaltose)

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Iron Deficiency Anaemia | Phase 3 | Status: COMPLETED | Results posted: 2018-05-22